US PRE-MARKET MOVERS: NVDA, INTC, BIDU, NVO, LHX, SMMT, HUM, FANG, ARMK
ORIGINAL · NewsquawkUS PRE-MARKET MOVERS: NVDA, INTC, BIDU, NVO, LHX, SMMT, HUM, FANG, ARMKRead originalHide original
ES -0.7% NQ -1.3% RTY -0.5% NVDA -3.7%: Ex-CEO Huang reportedly misled executives over affair with Megaspeed executive; US to issue rules restricting remote access to advanced AI chips INTC -5.2%: Faces proposed shareholder class action alleging it concealed weak PC demand & excess inventory BIDU -1.5%: Rev. slightly light, with online marketing rev. down 22% Y/Y NVO +1.3%: Positive Phase 3 results for lower-dose CagriSema LHX -3.1%: Faulty router it installed reportedly triggered nationwide US flight shutdown SMMT -13.0%: FDA rejects ivonescimab HUM +1.9%: RBC upgrades to Outperform, sees strong earnings potential FANG -2.0%: Agreed to buy Double Eagle subsidiaries for roughly 15.56mln shares & $2.15B in cash ARMK -5.8%: Profit light & FY27 EPS guidance below exp.
The pre-market list spans earnings, regulatory and company-specific catalysts, with Nvidia’s first post-Huang results due Tuesday and Diamondback’s acquisition expected to close December 21.
News detail
ES -0.7% NQ -1.3% RTY -0.5% NVDA -3.7%: Ex-CEO Huang reportedly misled executives over affair with Megaspeed executive; US to issue rules restricting remote access to advanced AI chips INTC -5.2%: Faces proposed shareholder class action alleging it concealed weak PC demand & excess inventory BIDU -1.5%: Rev. slightly light, with online marketing rev. down 22% Y/Y NVO +1.3%: Positive Phase 3 results for lower-dose CagriSema LHX -3.1%: Faulty router it installed reportedly triggered nationwide US flight shutdown SMMT -13.0%: FDA rejects ivonescimab HUM +1.9%: RBC upgrades to Outperform, sees strong earnings potential FANG -2.0%: Agreed to buy Double Eagle subsidiaries for roughly 15.56mln shares & $2.15B in cash ARMK -5.8%: Profit light & FY27 EPS guidance below exp.
Related stocks
9 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
